212 related articles for article (PubMed ID: 33013390)
1. The Botanical Drug PBI-05204, a Supercritical CO
Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Martellucci S; Conway TL; Chakraborty S; Marampon F; Mattei V; Gravina GL; Biordi AL; Wei D; Newman RA; Festuccia C
Front Pharmacol; 2020; 11():552428. PubMed ID: 33013390
[TBL] [Abstract][Full Text] [Related]
2. The Botanical Drug PBI-05204, a Supercritical CO
Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Chakraborty S; Martellucci S; Marampon F; Mattei V; Gravina GL; Iorio R; Newman RA; Festuccia C
Front Pharmacol; 2022; 13():852941. PubMed ID: 35401175
[TBL] [Abstract][Full Text] [Related]
3. PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway.
Pan Y; Rhea P; Tan L; Cartwright C; Lee HJ; Ravoori MK; Addington C; Gagea M; Kundra V; Kim SJ; Newman RA; Yang P
Invest New Drugs; 2015 Apr; 33(2):271-9. PubMed ID: 25476893
[TBL] [Abstract][Full Text] [Related]
4. PBI-05204, a supercritical CO
Chakraborty S; Wei D; Tran M; Lang FF; Newman RA; Yang P
Neoplasia; 2024 Aug; 54():101008. PubMed ID: 38823209
[TBL] [Abstract][Full Text] [Related]
5. The botanical drug PBI-05204, a supercritical CO
Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
7. Erratum: The Botanical Drug PBI-05204, a Supercritical CO
Frontiers Production Office
Front Pharmacol; 2022; 13():937601. PubMed ID: 35707399
[TBL] [Abstract][Full Text] [Related]
8. A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.
Roth MT; Cardin DB; Borazanci EH; Steinbach M; Picozzi VJ; Rosemury A; Wadlow RC; Newman RA; Berlin J
Oncologist; 2020 Oct; 25(10):e1446-e1450. PubMed ID: 32452588
[TBL] [Abstract][Full Text] [Related]
9. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models.
Dunn DE; He DN; Yang P; Johansen M; Newman RA; Lo DC
J Neurochem; 2011 Nov; 119(4):805-14. PubMed ID: 21950737
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects of progesterone in human glioblastoma multiforme: role of PI3K/Akt/mTOR signaling.
Atif F; Yousuf S; Stein DG
J Steroid Biochem Mol Biol; 2015 Feb; 146():62-73. PubMed ID: 24787660
[TBL] [Abstract][Full Text] [Related]
12. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
Gravina GL; Mancini A; Colapietro A; Vitale F; Vetuschi A; Pompili S; Rossi G; Marampon F; Richardson PJ; Patient L; Patient L; Burbidge S; Festuccia C
Tumour Biol; 2017 Jun; 39(6):1010428317695528. PubMed ID: 28639900
[TBL] [Abstract][Full Text] [Related]
13. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Wang J; Qi Q; Huang B; Chen A; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):2160-8. PubMed ID: 27498786
[TBL] [Abstract][Full Text] [Related]
14. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
15. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
16. Dual PI3K/mTOR Inhibitor, XL765, suppresses glioblastoma growth by inducing ER stress-dependent apoptosis.
Zhao H; Chen G; Liang H
Onco Targets Ther; 2019; 12():5415-5424. PubMed ID: 31360067
[No Abstract] [Full Text] [Related]
17. The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells.
Wang Y; Shen H; Sun Q; Zhao L; Liu H; Ye L; Xu Y; Cai J; Li Y; Gao L; Tan Y; Liu B; Chen Q
Front Pharmacol; 2021; 12():659511. PubMed ID: 34381355
[TBL] [Abstract][Full Text] [Related]
18. First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.
Hong DS; Henary H; Falchook GS; Naing A; Fu S; Moulder S; Wheler JJ; Tsimberidou A; Durand JB; Khan R; Yang P; Johansen M; Newman RA; Kurzrock R
Invest New Drugs; 2014 Dec; 32(6):1204-12. PubMed ID: 24919855
[TBL] [Abstract][Full Text] [Related]
19. Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.
Netland IA; Førde HE; Sleire L; Leiss L; Rahman MA; Skeie BS; Gjerde CH; Enger PØ; Goplen D
BMC Cancer; 2016 Aug; 16():657. PubMed ID: 27542970
[TBL] [Abstract][Full Text] [Related]
20. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]